Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RingCentral
RNG
|
+$36.8M |
| 2 |
Acadia Healthcare
ACHC
|
+$30.7M |
| 3 |
BILL Holdings
BILL
|
+$20.8M |
| 4 |
Omnicom Group
OMC
|
+$15.9M |
| 5 |
Equinox Gold
EQX
|
+$14.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNB
Dun & Bradstreet
DNB
|
+$33.6M |
| 2 |
SLB Ltd
SLB
|
+$23.7M |
| 3 |
Match Group
MTCH
|
+$22.9M |
| 4 |
Murphy Oil
MUR
|
+$19.4M |
| 5 |
Lyft
LYFT
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Consumer Discretionary | 17.8% |
| 3 | Healthcare | 16.38% |
| 4 | Industrials | 9.22% |
| 5 | Materials | 9.03% |
Similar funds
Invenomic Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.
- Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
- Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
- Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
- Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
- Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
- Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
- Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.
Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.